{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:51:07Z","timestamp":1760608267525},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":7489,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1002\/lt.500010207","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T18:48:50Z","timestamp":1134672530000},"page":"107-110","source":"Crossref","is-referenced-by-count":11,"title":["Overview: The management of metastatic carcinoid tumors"],"prefix":"10.1002","volume":"1","author":[{"given":"John K.","family":"Ramage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Catnach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,15]]},"reference":[{"key":"10.1002\/lt.500010207-BIB1|cit1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/02841868909111218","article-title":"Therapeutic considerations for the malignant carcinoid syndrome","volume":"28","author":"Kvols","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1002\/lt.500010207-BIB2|cit2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/pgmj.67.788.506","article-title":"Management of carcinoid syndrome","volume":"67","author":"Saini","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1002\/lt.500010207-BIB3|cit3","first-page":"322","article-title":"Carcinoid tumors","volume":"84","author":"Berge","year":"1976","journal-title":"Acta Pathol Microbiol Immunol Scand (A)"},{"key":"10.1002\/lt.500010207-BIB4|cit4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/02841868909111212","article-title":"Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management","volume":"28","author":"Vinik","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1002\/lt.500010207-BIB5|cit5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4","article-title":"Carcinoid tumors. An analysis of 2837 cases","volume":"36","author":"Godwin","year":"1975","journal-title":"Cancer"},{"key":"10.1002\/lt.500010207-BIB6|cit6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(86)90581-4","article-title":"Neuroendocrine tumors. A European view","volume":"81","author":"Buchanan","year":"1986","journal-title":"Am J Med"},{"key":"10.1002\/lt.500010207-BIB7|cit7","first-page":"1021","article-title":"Therapy for symptoms in the carcinoid syndrome","volume":"271","author":"Coupe","year":"1989","journal-title":"Q J Med"},{"key":"10.1002\/lt.500010207-BIB8|cit8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/02841868909111218","article-title":"Therapeutic considerations for the malignant carcinoid syndrome","volume":"28","author":"Kvols","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1002\/lt.500010207-BIB9|cit9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0950-3528(87)90033-9","article-title":"Carcinoid and neuroendocrine tumors of the liver","volume":"1","author":"Hodgson","year":"1987","journal-title":"Baillieres Clinical Gastroenterol"},{"key":"10.1002\/lt.500010207-BIB10|cit10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","article-title":"Treatment of the carcinoid tumor and the malignant carcinoid syndrome","volume":"1","author":"Moertel","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1002\/lt.500010207-BIB11|cit11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.1.5165.28","article-title":"A metastasising carcinoid tumor with unusual features","volume":"1","author":"Williams","year":"1960","journal-title":"BMJ"},{"key":"10.1002\/lt.500010207-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"10.1002\/lt.500010207-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0024-3205(82)90087-X","article-title":"SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action","volume":"31","author":"Bauer","year":"1982","journal-title":"Life Sci"},{"key":"10.1002\/lt.500010207-BIB14|cit14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1002\/lt.500010207-BIB15|cit15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0889-8553(21)00447-7","article-title":"The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors","volume":"18","author":"Maton","year":"1989","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1002\/lt.500010207-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/bmj.299.6708.1162-c","article-title":"Gallstones and treatment with octreotide for acromegaly","volume":"299","author":"Wass","year":"1989","journal-title":"BMJ"},{"key":"10.1002\/lt.500010207-BIB17|cit17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90582-6","article-title":"Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes","volume":"81","author":"Vinik","year":"1986","journal-title":"Am J of Med"},{"key":"10.1002\/lt.500010207-BIB18|cit18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/02841868909111220","article-title":"Interferon treatment in patients with malignant carcinoids","volume":"28","author":"Nobin","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1002\/lt.500010207-BIB19|cit19","first-page":"1297","article-title":"Treatment of malignant carcinoid tumors with human leucocyte interferon: long term results","volume":"70","author":"Oberg","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1002\/lt.500010207-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0277-5379(89)90107-7","article-title":"Treatment of malignant carcinoid tumors: A randomized controlled study of streptozotocin plus 5-FU and human leucocyte interferon","volume":"25","author":"Oberg","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1002\/lt.500010207-BIB21|cit21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058291","article-title":"Treatment with alpha-interferon versus alpha-interferon in combination with streptozotocin and doxorubicin in patients with malignant carcinoid tumors: a randomised trial","volume":"3","author":"Janson","year":"1992","journal-title":"Ann of Oncol"},{"key":"10.1002\/lt.500010207-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.1984.2.11.1255","article-title":"Streptozotocin plus flurouracil versus doxorubicin therapy for metastatic carcinoid tumors","volume":"2","author":"Engstrom","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1002\/lt.500010207-BIB23|cit23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02841868909111219","article-title":"Recombinant alpha 2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumors","volume":"28","author":"Hanssen","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1002\/lt.500010207-BIB24|cit24","first-page":"1024","article-title":"Prospective study of aggressive resection of metastatic pancreatic endocrine tumors","volume":"112","author":"Carty","year":"1992","journal-title":"Ann Surg"},{"key":"10.1002\/lt.500010207-BIB25|cit25","first-page":"341","article-title":"The surgical management of carcinoid tumors","volume":"35","author":"Zarrilli","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1002\/lt.500010207-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199011013231805","article-title":"Somatostatin-receptor imaging in the localization of endocrine tumors","volume":"323","author":"Lamberts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1002\/lt.500010207-BIB27|cit27","first-page":"1121","article-title":"A scintigraphic comparison of Iodine-123-metaiodobenzyl guanidine and an Iodine-labelled somatostatin analog (Tyr-3-Octreotide) in metastatic carcinoid tumors","volume":"33","author":"Bomanji","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1002\/lt.500010207-BIB28|cit28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00006231-199404000-00007","article-title":"Comparison of 111In-labelled octreotide and 123I-labelled metaiodobenzylguanidine (MIBG) imaging in patients with secondary carcinoid tumors of the liver","volume":"15","author":"Buxton-Thomas","year":"1994","journal-title":"Nucl Med Commun"},{"key":"10.1002\/lt.500010207-BIB29|cit29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00173045","article-title":"Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors","volume":"21","author":"Hoefnagel","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1002\/lt.500010207-BIB30|cit30","first-page":"343","article-title":"Results of 131Metaiodobenzylguanidine treatment in metastatic carcinoid","volume":"35","author":"Bestagno","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1002\/lt.500010207-BIB31|cit31","first-page":"349","article-title":"131 Metiodobenzylguanidine therapy in carcinoid tumors","volume":"35","author":"Castellani","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1002\/lt.500010207-BIB32|cit32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00006231-199310000-00004","article-title":"Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumors with 131I-metaiodobenzylguanidine","volume":"14","author":"Bomanji","year":"1993","journal-title":"Nucl Med Commun"},{"key":"10.1002\/lt.500010207-BIB33|cit33","first-page":"107","article-title":"Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas","volume":"168","author":"Makowka","year":"1989","journal-title":"Surg Gynecol Obstet"},{"key":"10.1002\/lt.500010207-BIB34|cit34","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"key":"10.1002\/lt.500010207-BIB35|cit35","article-title":"Liver transplantation for metastatic neuroendocrine tumors","volume":"25","author":"Schweizer","year":"1973","journal-title":"Trans Proc 1993"},{"key":"10.1002\/lt.500010207-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archsurg.1990.01410220045007","article-title":"Is liver transplantation justified for the treatment of hepatic malignancies","volume":"125","author":"Olthoff","year":"1990","journal-title":"Arch Surg"},{"key":"10.1002\/lt.500010207-BIB37|cit37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000658-198901000-00013","article-title":"The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence","volume":"209","author":"Ringe","year":"1989","journal-title":"Ann Surg"}],"container-title":["Liver Transplantation and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.500010207","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/lt.500010207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T15:54:20Z","timestamp":1626882860000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lt.500010207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,3]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.500010207","relation":{},"ISSN":["1074-3022"],"issn-type":[{"value":"1074-3022","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}